Director of Halozyme Therapeutics, Inc. (NASDAQ:HALO), Kelley Kenneth J, sells 5,000 shares worth $225,000
According to Halozyme Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 04:19 PM, company Director, Kelley Kenneth J disclosed selling 5,000 shares at a cost of $45.00. At the time of this transaction (Apr 14), this trade was worth $225,000 in total. As of Apr 14, Kelley Kenneth J now owns 179,833 shares in total worth about $8,263,326.350000001.
For the last few recent trades made by Halozyme Therapeutics, Inc. (NASDAQ:HALO) Director, Kelley Kenneth J, we have the following information:
- SEC Form 4 filing: Dec 07: Sold 35,086 shares at the rate of $41.00 per share. Total worth of this trade was $1,438,526. Total number of shares owned as of Dec 07 were 199,833
- SEC Form 4 filing: Dec 02: Sold 31,792 shares at the rate of $41.00 per share. Total worth of this trade was $1,303,472. Total number of shares owned as of Dec 02 were 234,919
- SEC Form 4 filing: Nov 25: Sold 9,671 shares at the rate of $41.50 per share. Total worth of this trade was $401,350. Total number of shares owned as of Nov 25 were 276,711
Posted by
George Daniels
on Wednesday April 14 2021, 6:58 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
